Article
Ribozyme as an approach for growth suppression of human pancreatic cancer.
Molecular biotechnology - 1 Jan 2000
Kijima H, Scanlon K J
Abstract excerpt
Ribozymes (catalytic RNAs, RNA enzymes) are effective modulators of gene expression because of their simple structure, site-specific cleavage activity, and catalytic potential, and have potentially important implications for cancer gene therapy. Point mutations in the K-ras oncogene are found in approx 90% of human pancreatic carcinomas, and can be used as potential targets for specific ribozyme-mediated reversal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
